These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1246 related articles for article (PubMed ID: 27996313)
1. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
2. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bone marrow 2-[ Lim CH; Hyun SH; Cho YS; Choi JY; Lee KH Clin Radiol; 2021 Jul; 76(7):550.e19-550.e28. PubMed ID: 33762136 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma. Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and Prognostic Value of Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma. El-Azony A; Basha MAA; Almalki YE; Abdelmaksoud B; Hefzi N; Alnagar AA; Mahdey S; Ali IM; Nasr I; Abdalla AAEM; Yousef HY; Zaitoun MMA; Elsayed SB; Nada MG; Amin MI; Hassan RM; Ali SA; Dawoud TM; Aly SA; Algazzar YH; Abdelhamed H Eur Radiol; 2024 Apr; 34(4):2500-2511. PubMed ID: 37812294 [TBL] [Abstract][Full Text] [Related]
8. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [ Liang X; Yang C; Su M; Zou L Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723 [TBL] [Abstract][Full Text] [Related]
12. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre Doma A; Zevnik K; Studen A; Prevodnik VK; Gasljevic G; Novakovic BJ Radiol Oncol; 2024 Mar; 58(1):15-22. PubMed ID: 38378029 [TBL] [Abstract][Full Text] [Related]
13. Utility of Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of bone marrow Lee JW; Lee SC; Kim HJ; Lee SM Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904 [TBL] [Abstract][Full Text] [Related]
15. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study. Alzahrani M; El-Galaly TC; Hutchings M; Hansen JW; Loft A; Johnsen HE; Iyer V; Wilson D; Sehn LH; Savage KJ; Connors JM; Gascoyne RD; Johansen P; Clasen-Linde E; Brown P; Villa D Ann Oncol; 2016 Jun; 27(6):1095-1099. PubMed ID: 27002106 [TBL] [Abstract][Full Text] [Related]
16. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378 [TBL] [Abstract][Full Text] [Related]
17. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma. Wu X; Pertovaara H; Korkola P; Vornanen M; Järvenpää R; Dastidar P; Eskola H; Kellokumpu-Lehtinen PL Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581 [TBL] [Abstract][Full Text] [Related]
18. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868 [TBL] [Abstract][Full Text] [Related]
19. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma]. Zhang Y; Zhou J; Wang L; Li JY; Ding CY Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633 [No Abstract] [Full Text] [Related] [Next] [New Search]